-
41
المؤلفون: Nicoletta Ranallo, Andrea Prochoswski Iamurri, Flavia Foca, Chiara Liverani, Alessandro De Vita, Laura Mercatali, Chiara Calabrese, Chiara Spadazzi, Carlo Fabbri, Davide Cavaliere, Riccardo Galassi, Stefano Severi, Maddalena Sansovini, Andreas Tartaglia, Federica Pieri, Laura Crudi, David Bianchini, Domenico Barone, Giovanni Martinelli, Giovanni Luca Frassineti, Toni Ibrahim, Luana Calabrò, Rossana Berardi, Alberto Bongiovanni
المصدر: Cancers; Volume 14; Issue 13; Pages: 3231
مصطلحات موضوعية: NET, Cancer Research, body composition, mTOR inhibitors, Oncology, muscle tissue, everolimus, adipose tissue, neuroendocrine tumors, NO
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d190f9da312016b6ab8d85379cfe442bTest
https://pubmed.ncbi.nlm.nih.gov/35805003Test -
42
المؤلفون: Sandeep Kumar, Shalmoli Bhattacharyya, Ashim Das, Gurpreet Singh, Amanjit Bal
المصدر: Breast disease. 41(1)
مصطلحات موضوعية: Cancer Research, Class I Phosphatidylinositol 3-Kinases, TOR Serine-Threonine Kinases, Breast Neoplasms, Triple Negative Breast Neoplasms, General Medicine, MTOR Inhibitors, Cell Line, Phosphatidylinositol 3-Kinases, Oncology, Receptors, Androgen, Cell Line, Tumor, Humans, Female, skin and connective tissue diseases, Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56b18720d9547f3d4f20290caa1976caTest
https://pubmed.ncbi.nlm.nih.gov/35431224Test -
43
المؤلفون: Tiffany Shaw, Hannah Lee, Robert A. Figlin
المصدر: ONCOLOGY. :306-310
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Cabozantinib, medicine.medical_treatment, Ipilimumab, chemistry.chemical_compound, Antineoplastic Agents, Immunological, Renal cell carcinoma, Internal medicine, Basic Helix-Loop-Helix Transcription Factors, medicine, Humans, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Randomized Controlled Trials as Topic, Everolimus, business.industry, MTOR Inhibitors, Immunotherapy, medicine.disease, Kidney Neoplasms, respiratory tract diseases, Axitinib, chemistry, Practice Guidelines as Topic, Nivolumab, business, Lenvatinib, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2384827fee72ba75eb3766c87f599354Test
https://doi.org/10.46883/onc.2021.3506.0306Test -
44دورية أكاديمية
المؤلفون: Kulke, Matthew H, Ou, Fang-Shu, Niedzwiecki, Donna, Huebner, Lucas, Kunz, Pamela, Kennecke, Hagen F, Wolin, Edward M, Chan, Jennifer A, O'Reilly, Eileen M, Meyerhardt, Jeffrey A, Venook, Alan
المصدر: Articles, Abstracts, and Reports
مصطلحات موضوعية: oregon, chiles, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Disease-Free Survival, Everolimus, Humans, MTOR Inhibitors, Neuroectodermal Tumors, Primitive, Vascular Endothelial Growth Factor A, Endocrinology, Diabetes, and Metabolism, Oncology
العلاقة: https://digitalcommons.psjhealth.org/publications/6100Test; https://pubmed.ncbi.nlm.nih.gov/35324465Test
-
45
المؤلفون: Peter Trnka, Sean E. Kennedy
المصدر: Pediatric Nephrology. 36:1427-1438
مصطلحات موضوعية: Nephrology, Oncology, congenital, hereditary, and neonatal diseases and abnormalities, medicine.medical_specialty, 030232 urology & nephrology, Usually asymptomatic, 030204 cardiovascular system & hematology, 03 medical and health sciences, Tuberous sclerosis, 0302 clinical medicine, Renal cell carcinoma, hemic and lymphatic diseases, Internal medicine, medicine, neoplasms, PI3K/AKT/mTOR pathway, Kidney, business.industry, Treatment options, medicine.disease, Discovery and development of mTOR inhibitors, nervous system diseases, medicine.anatomical_structure, embryonic structures, Pediatrics, Perinatology and Child Health, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b9cf6eca4808f732ca49e5d23e8aea80Test
https://doi.org/10.1007/s00467-020-04775-1Test -
46
المؤلفون: Veronica Mollica, Antonio Lopez-Beltran, Francesco Massari, Alessia Cimadamore, Ilaria Maggio, Michelangelo Fiorentino, Eugenio Brunocilla, Liang Cheng, Francesca Giunchi, Riccardo Schiavina, Alessandro Rizzo, Rodolfo Montironi
المساهمون: Mollica V., Maggio I., Lopez-Beltran A., Montironi R., Cimadamore A., Cheng L., Rizzo A., Giunchi F., Schiavina R., Fiorentino M., Brunocilla E., Massari F.
المصدر: Expert Review of Anticancer Therapy. 20:755-763
مصطلحات موضوعية: 0301 basic medicine, Metastatic Urothelial Carcinoma, Combination therapy, Receptor, ErbB-2, Immune checkpoint inhibitors, Poly ADP ribose polymerase, Disease, Poly(ADP-ribose) Polymerase Inhibitors, DDR, PI3K, 03 medical and health sciences, 0302 clinical medicine, Drug Development, Antineoplastic Combined Chemotherapy Protocols, Humans, DNA damage repair, Urothelial cancer, Medicine, Pharmacology (medical), PARP inhibitors, Immune Checkpoint Inhibitors, urothelial carcinoma, PI3K/AKT/mTOR pathway, Neoplasm Staging, Carcinoma, Transitional Cell, business.industry, TOR Serine-Threonine Kinases, HER-2, mTOR, Discovery and development of mTOR inhibitors, PARP inhibitor, 030104 developmental biology, Urinary Bladder Neoplasms, Oncology, 030220 oncology & carcinogenesis, Cancer research, business
وصف الملف: STAMPA
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97aeadce830c00f905b74248e83e9037Test
https://doi.org/10.1080/14737140.2020.1807334Test -
47
المؤلفون: David Casadevall, Anna Hernández-Prat, Sara García-Alonso, Oriol Arpí-Llucià, Silvia Menéndez, Mengjuan Qin, Cristina Guardia, Beatriz Morancho, Francisco Javier Sánchez-Martín, Sandra Zazo, Elena Gavilán, Mohammad A. Sabbaghi, Pilar Eroles, Juan Miguel Cejalvo, Ana Lluch, Federico Rojo, Atanasio Pandiella, Ana Rovira, Joan Albanell
المساهمون: Instituto de Salud Carlos III, Generalitat de Catalunya, Ministerio de Economía y Competitividad (España), Fundación CRIS contra el Cáncer, China Scholarship Council, European Commission
المصدر: Digital.CSIC. Repositorio Institucional del CSIC
instnameمصطلحات موضوعية: musculoskeletal diseases, Inhibition of mTOR increases the antitumor activity of T-DM1, congenital, hereditary, and neonatal diseases and abnormalities, Cancer Research, Immunoconjugates, Receptor, ErbB-2, TOR Serine-Threonine Kinases, Breast Neoplasms, Mechanistic Target of Rapamycin Complex 1, Trastuzumab, Ado-Trastuzumab Emtansine, Antibodies, Monoclonal, Humanized, Antibody-drug conjugates warrants clinical evaluation in patients with HER2-positive breast cancer, Xenograft Model Antitumor Assays, Mice, Supporting that the combination of mTOR inhibitors, Oncology, Cell Line, Tumor, Animals, Humans, Female, Everolimus, skin and connective tissue diseases, Molecular Biology
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3656e1cb422ad1d2aa23e9ba81826192Test
http://hdl.handle.net/10261/282954Test -
48Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancer
المؤلفون: M. D. Torregrosa-Maicas, S. del Barco-Berrón, A. Cotes-Sanchís, L. Lema-Roso, S. Servitja-Tormo, R. Gironés-Sarrió
المصدر: CLINICAL & TRANSLATIONAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Feمصطلحات موضوعية: mTOR inhibitors, Cancer Research, Consensus, Receptor, ErbB-2, Age Factors, Breast Neoplasms, General Medicine, PI3K inhibitors, Cyclin inhibitors, Oncology, Geriatrics, Quality of Life, Humans, Female, Breast, Hormone therapy, PARP inhibitors, Geriatric Assessment, Aged
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ebf37a0a254a113de200e3f3fdca245Test
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=12843Test -
49
المؤلفون: Klaus Warnatz, Kohsuke Imai, Bénédicte Neven, Mette Holm, Ulrich Duffner, B Carpenter, Musa Karakukcu, Hassan Abolhassani, Robert Wynn, Neena Kapoor, Jennifer A. Kanakry, Marina Garcia-Prat, Mariacristina Menconi, Anna Mukhina, Pere Soler-Palacín, Takahiro Tomoda, Claudia Wehr, Diana K. Bayer, Eleonora Gambineri, Gulbu Uzel, Austen Worth, Arunkumar Modi, Mary Slatter, Tania Nicole Masmas, Dimana Dimitrova, Carsten Speckmann, J.J. Bleesing, Shankara Paneesha, Kanchan Rao, Sylwia Kołtan, Carmem Bonfim, Jasmeen Dara, Colin G. Steward, Winnie Ip, Emma C. Morris, Asghar Aghamohammadi, Andrew R. Gennery, Gašper Markelj, Luigi D. Notarangelo, Stephen M. Hughes, Sujal Ghosh, Tsubasa Okano, Ansgar Schulz, Arjan C. Lankester, Stephen Jolles, Ebru Yilmaz, Alexandra Laberko, Maria Elena Maccari, Stephan Ehl, Christopher C. Dvorak, Despina Moshous, Hyoung Jin Kang, Carolina Prando, Zohreh Nademi
المساهمون: Institut Català de la Salut, [Dimitrova D] Experimental Transplantation and Immunotherapy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md. [Nademi Z] Children’s Bone Marrow Transplant Unit, Great North Children’s Hospital, Newcastle upon Tyne, United Kingdom. The Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom. [Maccari ME, Ehl S] Department of Pediatric Hematology and Oncology, Center for Pediatrics, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Center for Chronic Immunodeficiency, Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. [Uzel G] Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md. [Tomoda T] Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan. [Garcia-Prat M, Soler-Palacín P] Unitat de Patologia Infecciosa i Immunodeficiències de Pediatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Dimitrova, D, Nademi, Z, Maccari, M E, Ehl, S, Uzel, G, Tomoda, T, Okano, T, Imai, K, Carpenter, B, Ip, W, Rao, K, Worth, A J J, Laberko, A, Mukhina, A, Néven, B, Moshous, D, Speckmann, C, Warnatz, K, Wehr, C, Abolhassani, H, Aghamohammadi, A, Bleesing, J J, Dara, J, Dvorak, C C, Ghosh, S, Kang, H J, Markelj, G, Modi, A, Bayer, D K, Notarangelo, L D, Schulz, A, Garcia-Prat, M, Soler-Palacín, P, Karakükcü, M, Yilmaz, E, Gambineri, E, Menconi, M, Masmas, T N, Holm, M, Bonfim, C, Prando, C, Hughes, S, Jolles, S, Morris, E C, Kapoor, N, Koltan, S, Paneesha, S, Steward, C, Wynn, R, Duffner, U, Gennery, A R, Lankester, A C, Slatter, M & Kanakry, J A 2022, ' International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome ', Journal of Allergy and Clinical Immunology, vol. 149, no. 1, pp. 410-421.e7 . https://doi.org/10.1016/j.jaci.2021.04.036Test
The Journal of allergy and clinical immunology, vol 149, iss 1
Journal of Allergy and Clinical Immunology, 149(1), 410-421. MOSBY-ELSEVIER
The Journal of allergy and clinical immunology
Dimitrova, D, Nademi, Z, Maccari, M E, Ehl, S, Uzel, G, Tomoda, T, Okano, T, Imai, K, Carpenter, B, Ip, W, Rao, K, Worth, A J J, Laberko, A, Mukhina, A, Néven, B, Moshous, D, Speckmann, C, Warnatz, K, Wehr, C, Abolhassani, H, Aghamohammadi, A, Bleesing, J J, Dara, J, Dvorak, C C, Ghosh, S, Kang, H J, Markelj, G, Modi, A, Bayer, D K, Notarangelo, L D, Schulz, A, Garcia-Prat, M, Soler-Palacín, P, Karakükcü, M, Yilmaz, E, Gambineri, E, Menconi, M, Masmas, T N, Holm, M, Bonfim, C, Prando, C, Hughes, S, Jolles, S, Morris, E C, Kapoor, N, Koltan, S, Paneesha, S, Steward, C, Wynn, R, Duffner, U, Gennery, A R, Lankester, A C, Slatter, M & Kanakry, J A 2022, ' International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome ', The Journal of allergy and clinical immunology, vol. 149, no. 1, pp. 410-421.e7 . https://doi.org/10.1016/j.jaci.2021.04.036Test
Scientiaمصطلحات موضوعية: Graft Rejection, Male, 0301 basic medicine, Oncology, Allergy, lymphoproliferation, mTOR inhibitor, Kaplan-Meier Estimate, Regenerative Medicine, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, hemic and lymphatic diseases, Immunology and Allergy, Cumulative incidence, Child, Otros calificadores::/terapia [Otros calificadores], Immunodeficiency, Cancer, Primary immunodeficiency, Hematopoietic Stem Cell Transplantation, MTOR Inhibitors, Hematology, Middle Aged, Síndromes de deficiència immunitària - Tractament, enfermedades del sistema inmune::síndromes de inmunodeficiencia [ENFERMEDADES], Treatment Outcome, surgical procedures, operative, Child, Preschool, Immune System Diseases::Immunologic Deficiency Syndromes [DISEASES], Female, terapéutica::terapia biológica::tratamientos basados en células y tejidos::trasplante de células::trasplante de células madre::trasplante de células madre hematopoyéticas [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Homologous, Adult, medicine.medical_specialty, activated phosphoinositide 3-kinase delta syndrome, Adolescent, Class I Phosphatidylinositol 3-Kinases, Primary Immunodeficiency Diseases, graft failure, Immunology, serotherapy, Activated PI3K-delta syndrome, Context (language use), Article, Young Adult, 03 medical and health sciences, Rare Diseases, Internal medicine, medicine, Transplantation, Homologous, Humans, Preschool, Retrospective Studies, Aged, Transplantation, allogeneic hematopoietic cell transplantation, Cèl·lules mare hematopoètiques - Trasplantació, business.industry, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Retrospective cohort study, Other subheadings::/therapy [Other subheadings], Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, 030104 developmental biology, Graft-versus-host disease, allogeneic hemato-poietic cell transplantation, Avaluació de resultats (Assistència sanitària), Therapeutics::Biological Therapy::Cell- and Tissue-Based Therapy::Cell Transplantation::Stem Cell Transplantation::Hematopoietic Stem Cell Transplantation [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], business, 030215 immunology
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fff24621d0b56e0aaf43e9d30b95d29eTest
https://hdl.handle.net/1887/3277790Test -
50دورية أكاديمية
المؤلفون: Al-Saffar, Nada M. S., Agliano, Alice, Marshall, Lynley V., Jackson, L. Elizabeth, Balarajah, Geetha, Sidhu, Jasmin, Clarke, Paul A., Jones, Chris, Workman, Paul, Pearson, Andrew D. J., Leach, Martin O.
المصدر: PLoS ONE; 7/13/2017, Vol. 12 Issue 7, p1-16, 16p
مصطلحات موضوعية: GLIOBLASTOMA multiforme, BIOMARKERS, NUCLEAR magnetic resonance spectroscopy, MTOR inhibitors, TEMOZOLOMIDE, CLINICAL trials, CHILD patients, DIAGNOSIS